v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenue:    
Product revenue $ 401 $ 0
Cost and expenses:    
Cost of product revenue 370 0
Research and development 12,590 10,313
Selling, general and administrative 6,591 7,731
Total cost and expenses 19,551 18,044
Loss from operations (19,150) (18,044)
Other income (expense):    
Interest income 593 1,255
Other expense (24) (6)
Total other income 569 1,249
Net loss (18,581) (16,795)
Comprehensive loss $ (18,581) $ (16,795)
Net loss per share, basic and diluted (in dollars per share) $ (0.27) $ (0.25)
Weighted average common shares outstanding, basic and diluted (in shares) 67,994,566 67,125,967